These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2006001)

  • 1. Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: an update.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; McBride RG; Sherry KM
    Neurology; 1991 Mar; 41(3):363-4. PubMed ID: 2006001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; Napoliello MJ; Sherry KM; Szabo GK
    Neurology; 1987 Feb; 37(2):184-9. PubMed ID: 3808298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin in complex partial seizures: a long-term study.
    Cocito L; Maffini M; Perfumo P; Roncallo F; Loeb C
    Epilepsy Res; 1989; 3(2):160-6. PubMed ID: 2707251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
    Remy C; Beaumont D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin: a three year clinical analysis.
    Martin PJ; Millac PA
    Seizure; 1993 Jun; 2(2):137-40. PubMed ID: 8167965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.
    Tartara A; Manni R; Galimberti CA; Morini R; Mumford JP; Iudice A; Perucca E
    Acta Neurol Scand; 1992 Sep; 86(3):247-51. PubMed ID: 1414241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathology of a human hippocampus following long-term treatment with vigabatrin: lack of microvacuoles.
    Agosti R; Yasargil G; Egli M; Wieser HG; Wiestler OD
    Epilepsy Res; 1990 Jul; 6(2):166-70. PubMed ID: 2387287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study.
    Sivenius J; Ylinen A; Murros K; Mumford JP; Riekkinen PJ
    Neurology; 1991 Apr; 41(4):562-5. PubMed ID: 1901397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin in the treatment of complex partial seizures.
    Knott C; Panayiotopoulos CP
    Seizure; 1992 Sep; 1(3):167-72. PubMed ID: 1344762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to vigabatrin in relation to seizure type.
    Michelucci R; Tassinari CA
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):119S-124S. PubMed ID: 2667603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
    Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen PJ
    Arch Neurol; 1993 Jan; 50(1):24-9. PubMed ID: 8418797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre study of vigabatrin for drug-resistant epilepsy.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; Miketta RM; Sherry KM; Szabo GK
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):95S-100S. PubMed ID: 2667606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open, double-blind and long-term study of vigabatrin in chronic epilepsy.
    Reynolds EH; Ring HA; Farr IN; Heller AJ; Elwes RD
    Epilepsia; 1991; 32(4):530-8. PubMed ID: 1868811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin in chronic epilepsy: a 7-year follow-up study of responder patients.
    Cocito L; Maffini M; Loeb C
    Seizure; 1993 Dec; 2(4):301-7. PubMed ID: 8162400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy.
    Tassinari CA; Michelucci R; Ambrosetto G; Salvi F
    Arch Neurol; 1987 Sep; 44(9):907-10. PubMed ID: 2887152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
    Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study.
    Luna D; Dulac O; Pajot N; Beaumont D
    Epilepsia; 1989; 30(4):430-7. PubMed ID: 2502384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy.
    Mumford JP; Dam M
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):101S-107S. PubMed ID: 2667602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind dose reduction study of vigabatrin in complex partial epilepsy.
    Sivenius MR; Ylinen A; Murros K; Matilainen R; Riekkinen P
    Epilepsia; 1987; 28(6):688-92. PubMed ID: 3319536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.